Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Tobias Kapp, PhD
Global Head of Peptide Development at CordenPharma
Speaker

Profile

Tobias Kapp is the Global Head Peptide Development at CordenPharma. In this role he oversees the development activities on all of CordenPharma`s Peptide sites and works closely at the interface of development and scale up for all process stages for both solid phase and liquid phase processes. Additionally, he is involved in the evaluation and implementation of new and innovative technologies. He is an organic and peptide chemist by training and earned his PhD under the supervision of Prof. Kessler at the Technical University of Munich where he worked on the development and medicinal application of subtype selective peptide ligands for integrins and CXCR4. After his PhD he started his career in the peptide CDMO industry, where he worked in scale up development of up- and downstream SPPS processes hands on and later in different leadership roles.

Agenda Sessions

  • Accelerate Timeline to Start PhI: Phase Appropriate Development and Integrated Drug Product Supply

    14:30